RISPERIDONE-AS risperidone 2mg film-coated tablet blister pack

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

risperidone, Quantity: 2 mg

Disponible desde:

Medis Pharma Pty Ltd

Designación común internacional (DCI):

Risperidone

formulario farmacéutico:

Tablet, film coated

Composición:

Excipient Ingredients: maize starch; magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; iron oxide red; hypromellose; lactose monohydrate; quinoline yellow; titanium dioxide; macrogol 400

Vía de administración:

Oral

Unidades en paquete:

60 tablets

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Risperidone-AS is indicated for the treatment of schizophrenia and related psychoses. Risperidone-AS is indicated for the treatment of behavioural disturbances in dementia. Risperidone-AS is indicated for the treatment of conduct and other disruptive disorders in children (over 5 years), adolescents and adults with sub average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent. (See Clinical Trials for maintenance data).

Resumen del producto:

Visual Identification: Orange, film-coated, oblong tablet engraved with "R", a breakline and "2" on one side and a plain face on the other.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 4 Years; Container Temperature: Store below 25 degrees Celsius

Estado de Autorización:

Licence status A

Fecha de autorización:

2012-09-26